Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Takeda To Buy Brazil’s Multilab
by Ann M. Thayer
June 4, 2012
| A version of this story appeared in
Volume 90, Issue 23
Takeda Pharmaceutical has agreed to acquire Brazil’s Multilab Indústria e Comércio de Produtos Farmacêuticos for $249 million up front and up to $20 million in milestone payments. In 2011, Multilab had sales of $70 million, primarily of branded generic and over-the-counter drugs. Takeda already manufactures prescription and OTC products in the country. According to the Japanese company, buying 24-year-old Multilab will make it one of the top 10 pharmaceutical companies in Brazil.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter